Arcturus Therapeutics Holdings (ARCT) EPS (Basic) Growth (1y) (2019 - 2026)
Arcturus Therapeutics Holdings (ARCT) EPS (Basic) Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -51.11% |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 186.69% |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 104.24% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -79.34% |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -52.19% |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -100.01% |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 61.11% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Arcturus Therapeutics Holdings | 202.50 Mn | -8.88 Mn | - | -82.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -82.69% |
| Dec 31, 2025 | 5.41% |
| Sep 30, 2025 | -88.46% |
| Jun 30, 2025 | 46.88% |
| Mar 31, 2025 | 48.00% |
| Dec 31, 2024 | -152.27% |
| Sep 30, 2024 | 57.38% |
| Jun 30, 2024 | 67.68% |
| Mar 31, 2024 | -152.36% |
| Dec 31, 2023 | -109.91% |
| Sep 30, 2023 | 54.14% |
| Jun 30, 2023 | -141.46% |
| Mar 31, 2023 | 198.45% |
| Dec 31, 2022 | 402.04% |
| Sep 30, 2022 | 35.12% |
| Jun 30, 2022 | 60.39% |
| Mar 31, 2022 | 9.77% |
| Dec 31, 2021 | -17.60% |
| Sep 30, 2021 | -122.83% |
| Jun 30, 2021 | -276.36% |